Financials
- Fiscal year
- 2024
- Total assets
- €3.8m
- Loss
- -€11.0m
- Solvency
- -207.5%
Total assets▼ 69.9%
Net result
20182024
PDC line Pharma
Dissolution or liquidationOverview
Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€3.8mtotal assets 2024
- Staff
- 22.4 FTE
- Equity
- -€7.8m
- Loss
- -€11.0m
Financial health
Dissolution or liquidation: no score
Structure
- Largest shareholder
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 21.46%
- Holdings
- 1
1 of 25 deeds read
Signals- Negative equity- Register: dissolution or liquidationFiled after the deadlineShow the evidence
Signals
Three signals.
+raises risk○neutral
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year -€7.8m
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-08-2025, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
26 days late
2023
33 days early
2022
43 days early
2021
54 days early
2020
38 days early
2019
37 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (1)
- Registered officeCourt decision · Registered-office move
- Annual accounts filedfiscal year 2024 · full…
- Weakest financial yearnet -€11.0m
Key points
By topic
Board & ownership
- Largest shareholder
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 21.46%
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 13
- Since
- 2017
- 28-06-2024Annual accounts filed
- 18-06-2023Annual accounts filed
- 07-06-2022Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Research and development on biotechnologyNACE 72101
- Founded
- 30-06-2016
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
Who ran this company, and where was it based, on a date before the end?Company as of a date How is the Research and development on biotechnology sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.